Masakazu Imamura
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Immune Cell Function and Interaction, Metabolism, Diabetes, and Cancer, Gastrointestinal Tumor Research and Treatment
Most-Cited Works
- → Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria(2011)340 cited
- → Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice(2013)307 cited
- → Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure(2002)281 cited
- → Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors(2001)272 cited
- → Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant(2010)177 cited
- → Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects(2016)144 cited
- → Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade(2005)140 cited
- → Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus(2012)130 cited
- → Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats(2014)122 cited
- → Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo(2011)108 cited